Steroid 5α-reductase inhibitors in androgen-dependent disorders
- 31 August 1997
- journal article
- Published by Elsevier in Current Opinion in Chemical Biology
- Vol. 1 (2) , 254-259
- https://doi.org/10.1016/s1367-5931(97)80017-8
Abstract
No abstract availableKeywords
This publication has 45 references indexed in Scilit:
- 5α-Reductase 1 and 2 expression and activity in human ovarian follicles, stroma and corpus luteum as compared to neonatal foreskinThe Journal of Steroid Biochemistry and Molecular Biology, 1996
- Effect of MK-386, a novel inhibitor of type 1 5 alpha-reductase, alone and in combination with finasteride, on serum dihydrotestosterone concentrations in menJournal of Clinical Endocrinology & Metabolism, 1996
- MK386: a potent, selective inhibitor of the human type 1 5α-reductaseThe Journal of Steroid Biochemistry and Molecular Biology, 1996
- Finasteride therapy does not alter bone turnover in men with benign prostatic hyperplasia--a Clinical Research Center studyJournal of Clinical Endocrinology & Metabolism, 1996
- Immunohistochemical evidence for differential distribution of 5α-reductase isoenzymes in human skinBritish Journal of Dermatology, 1995
- Polycystic ovary syndrome as a form of functional ovarian hyperandrogenism due to dysregulation of androgen secretionEndocrine Reviews, 1995
- The androgen control of sebum production. Studies of subjects with dihydrotestosterone deficiency and complete androgen insensitivityJournal of Clinical Endocrinology & Metabolism, 1993
- Prolonged treatment with finasteride (a 5α‐reductase inhibitor) does not affect bone density and metabolismClinical Endocrinology, 1992
- Finasteride, an inhibitor of 5 alpha-reductase, suppresses prostatic dihydrotestosterone in men with benign prostatic hyperplasiaJournal of Clinical Endocrinology & Metabolism, 1992
- Treatment of hirsutism with the pure antiandrogen flutamideJournal of the American Academy of Dermatology, 1990